Displaying 621 - 640 of 2119
Concurring Statement of Acting Chairwoman Rebecca Kelly Slaughter joined by Commissioner Rohit Chopra regarding the Revised Clayton Act Thresholds
FTC Announces Annual Update of Size of Transaction Thresholds for Premerger Notification Filings and Interlocking Directorates
FTC, DOJ Temporarily Suspend Discretionary Practice of Early Termination
Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding the Commission's Indefinite Suspension of Early Terminations
Following Federal Trade Commission Staff Recommendation to Challenge Transaction, Tronox Holding plc. Abandons Proposed Acquisition of TiZir Titanium and Iron
FTC Approves Final Order Imposing Conditions on Combination of Pfizer Inc.’s Upjohn and Mylan N.V.
Pfizer/Mylan, In the Matter of
Pharmaceutical companies Pfizer Inc. and Mylan N.V. have agreed to divest assets and abide by other conditions to settle Federal Trade Commission charges that the proposed combination of Upjohn Inc. and Mylan N.V. will harm current or future competition in ten generic drug markets. The FTC’s complaint alleges that the proposed combination would harm current U.S. competition in seven product markets by reducing the number of existing suppliers, and that it would harm future U.S. competition in three additional product markets. The proposed consent order requires divestitures in all 10 markets.
FTC Again Charges Endo and Impax with Illegally Preventing Competition in U.S. Market for Oxymorphone ER
FTC Acting Chair Rebecca Kelly Slaughter Announces Interim Leadership Appointments
FTC Publishes Annual Performance Report
FTC Chairman Simons Announces his Resignation and the Departure of Senior Staff
Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding the Commission’s Advocacy to the Department of Veterans Affairs
FTC Comment to Department of Veterans Affairs Supports Agency’s Interim Final Rule on VA Professionals’ Authority to Practice Health Care
Dissenting Statement of Commissioner Rohit Chopra Regarding the Commission's Advocacy to the Department of Veterans Affairs
Dissenting Statement of Commissioner Rebecca Kelly Slaughter Regarding the FTC Staff Comment on the VA's Interim Final Rule on the Authority of VA Professionals to Practice Health Care
FTC to Study the Impact of Physician Group and Healthcare Facility Mergers
FTC Publishes Inflation-Adjusted Civil Penalty Amounts for 2021
Statement of Ian Conner, Director of the FTC’s Bureau of Competition, Regarding the Announcement that The Procter & Gamble Company has Abandoned Its Proposed Acquisition of Billie, Inc.
Displaying 621 - 640 of 2119